The role and function of PPARγ in bladder cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor involved in various physiological and pathological processes.
• PPARγ's role in tumorigenesis is established, but its specific function in bladder cancer remains controversial.
• Bladder cancer is characterized by frequent relapses, necessitating research into novel therapeutic targets.

Purpose of the Study:

• To review and synthesize current literature on the expression and function of PPARγ in bladder cancer.
• To explore the mechanisms by which PPARγ influences bladder cancer progression, including proliferation, apoptosis, metastasis, and metabolism.
• To investigate the potential of PPARγ ligands as therapeutic agents for bladder cancer.

Main Methods:

• Comprehensive literature review of studies investigating PPARγ in bladder cancer.
• Analysis of signaling pathways implicated in PPARγ-mediated bladder cancer effects (e.g., PPARγ-SIRT1, PI3K-Akt, WNT/β-catenin).
• Examination of the relationship between PPARγ and chemotherapy sensitivity in bladder cancer.

Main Results:

• PPARγ influences bladder cancer by regulating cell proliferation, apoptosis, metastasis, and metabolic processes.
• PPARγ exerts its effects through pathways including PPARγ-SIRT1 feedback loops, PI3K-Akt, and WNT/β-catenin signaling.
• PPARγ expression and function in bladder cancer are complex and context-dependent.
• PPARγ ligands show potential as therapeutic targets for bladder cancer, potentially improving chemotherapy sensitivity.

Conclusions:

• PPARγ has a multifaceted role in bladder cancer, impacting its occurrence and progression.
• Targeting PPARγ pathways offers a promising avenue for novel bladder cancer therapies.
• Further research is warranted to fully elucidate PPARγ's complex functions and therapeutic potential in bladder cancer.